Andy Rachleff
| Andy Rachleff | |
|---|---|
| Alma mater | University of Pennsylvania, Stanford University |
| Occupation | Executive chairman of Wealthfront, Stanford Graduate School of Business Professor |
| Spouse(s) | Debra Rachleff |
Andy Rachleff is a co-founder and CEO of Wealthfront. He had previously been the executive chairman of the company after stepping down as the CEO, but then returned to the CEO role on October 31, 2016. Rachleff co-founded Benchmark Capital in 1995 and was a general partner until 2004. Prior to Benchmark, Rachleff was a general partner with Merrill, Pickard, Anderson & Eyre.
Rachleff co-founded Benchmark Capital, a venture capital firm, in 1995. The firm invested in companies including eBay, OpenTable, Snapchat, Twitter and Uber. Rachleff led investments in Blue Coat Systems, Equinix and Juniper Networks.
In 2000, Rachleff joined the University of Pennsylvania Board of Overseers for the school of engineering. He retired from Benchmark Capital in late 2004 and began teaching technology entrepreneurship courses at Stanford Graduate School of Business in January 2005. In 2005, he also joined the University of Pennsylvania board of trustees where he is Vice Chairman of the university's endowment investment committee and a member of the executive committee.
Rachleff and his wife, Debra, partnered with the Damon Runyon Cancer Research Foundation in 2007 to fund novel cancer research projects that did not receive funding from the National Institutes of Health.
In 2008, Rachleff co-founded Wealthfront (formerly known as kaChing). In December 2011, the company launched its automated investment service. Rachleff was the CEO and president until Adam Nash succeeded him on January 1, 2014. He is executive chairman of the company.
Rachleff teaches courses on technology entrepreneurship at Stanford Graduate School of Business. He is a trustee of the University of Pennsylvania, chairman of the board of overseers for its School of Engineering and Applied Science and vice chairman of its endowment investment committee. He is also a board member of the Damon Runyon Cancer Research Foundation.
...
Wikipedia